Provided by Tiger Trade Technology Pte. Ltd.

Olema Pharmaceuticals, Inc.

25.36
+0.35001.40%
Post-market: 25.860.5000+1.97%18:42 EST
Volume:962.29K
Turnover:24.72M
Market Cap:1.99B
PE:-14.04
High:26.48
Open:25.57
Low:25.24
Close:25.01
52wk High:36.26
52wk Low:2.86
Shares:78.66M
Float Shares:53.14M
Volume Ratio:0.52
T/O Rate:1.81%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-1.8064
EPS(LYR):-2.2041
ROE:-59.22%
ROA:-34.41%
PB:6.49
PE(LYR):-11.51

Loading ...

Jan 30, 2026

Major Issues Report

Form 8-K - Current report
Jan 20, 2026

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Jan 15, 2026

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Jan 14, 2026

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Jan 14, 2026

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Jan 13, 2026

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Jan 13, 2026

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Jan 12, 2026

Major Issues Report

Form 8-K - Current report
Jan 12, 2026

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Dec 23, 2025

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Dec 23, 2025

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Dec 22, 2025

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Dec 19, 2025

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Dec 19, 2025

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Dec 19, 2025

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Nov 19, 2025

Major Issues Report

Form 8-K - Current report
Nov 18, 2025

Major Issues Report

Form 8-K - Current report
Nov 10, 2025

Quarterly Report

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
Nov 10, 2025

Major Issues Report

Form 8-K - Current report
Oct 20, 2025

Major Issues Report

Form 8-K - Current report